Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.
It’s increasingly hard to find a bodily system that isn’t touched in some way by the drugs. Researchers are also investigating how these drugs might affect fertility and exploring their ...
In drug discovery ... Alnylam’s chief technology officer. In this way, the RNAi therapeutic platform is analogous to a computer operating system like iOS or Android; scientists can use the ...
An analysis of more than 77,000 patients in England found the country’s wealthiest patients were 27 per cent more likely to be prescribed the drugs than the most deprived. “When access to any ...
A new study has found that users of Ozempic or a similar drug had a 40% lower rate of opioid ... These types of medications interact with the mesolimbic system — a major reward center in the ...
A man jailed for his role in a million-pound drug dealing operation has spoken of how his time in prison offered him a “way out” of the ... Samantha Graham, CEO of Clean Sheet, which helps ...